Showing results (201-210 of 586) with videos related to
Sort By:
Pageof 59
The Pediatric Infectious Disease Journal|October 1, 1987
Cefixime: spectrum of antibacterial activity against 16,016 clinical isolatesA L Barry, R N JonesAmerican Journal of Clinical Pathology|May 1, 1977
Reliability of the microdilution technic for detection of methicillin-resistant strains of staphylococcus aureusA L Barry, R E BadalJournal of Clinical Microbiology|August 1, 1982
Reliability of early identifications obtained with Enterobacteriaceae-plus biochemical cards in the automicrobic systemA L Barry, R E BadalJournal of Clinical Microbiology|May 1, 1992
Performance of Haemophilus Test Media prepared with 12 different lots of Mueller-Hinton agar from four manufacturersA L Barry, R R PackerAntimicrobial Agents and Chemotherapy|May 1, 1987
Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serumR N Jones, A L BarryAmerican Journal of Clinical Pathology|January 1, 1979
In-vitro methods for determining minimal lethal concentrations of antimicrobial agentsA L Barry, R A LasnerDiagnostic Microbiology and Infectious Disease|December 1, 1987
In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibitionR N Jones, A L BarryThe Journal of Antimicrobial Chemotherapy|November 1, 1988
Interpretative criteria for the agar diffusion susceptibility test with azithromycinA L Barry, R N JonesAntimicrobial Agents and Chemotherapy|April 1, 1988
Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)R N Jones, A L BarryJournal of Clinical Microbiology|April 1, 1988
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephemR N Jones, A L BarryPageof 59